Ortho-Clinical Diagnostics Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Ortho-Clinical Diagnostics Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 In Vitro Diagnostics 11
3.1.1 Clinical Chemistry 11
3.1.2 Immuno Chemistry 11
4 Company Snapshot 12
4.1 Key Information 12
4.2 Company Overview 12
4.3 SWOT Snapshot 12
4.4 Business Overview 13
4.5 Major Products and Services 14
4.5.1 Overview 14
5 History 15
6 SWOT Analysis 18
6.1 Overview 18
6.2 Ortho-Clinical Diagnostics Inc. Strengths 18
6.2.1 IVD Product Portfolio 18
6.2.2 Improving Market Share in Global IVD Segment 18
6.2.3 The VITROS Family of Systems 19
6.3 Ortho-Clinical Diagnostics Inc. Weaknesses 19
6.3.1 Product Recalls 19
6.4 Ortho-Clinical Diagnostics Inc. Opportunities 19
6.4.1 Public-Private Partnership: US and China 19
6.4.2 Product Pipeline and New Product Launches 19
6.4.3 Expansion Strategy 20
6.5 Ortho-Clinical Diagnostics Inc. Threats 20
6.5.1 Increasing Competition 20
6.5.2 Regulatory Environment 20
6.5.3 Evolving Technological Environment 20
7 Competitors 21
8 Competitive Landscape 22
8.1 In Vitro Diagnostics(Clinical Chemistry), Global, Market Share (%), 2011 22
8.2 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Clinical Chemistry)by Region, Market Share (2011) 23
8.3 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Clinical Chemistry), by Country, Market Share (2011) 24
8.4 In Vitro Diagnostics(Immuno Chemistry), Global, Market Share (%), 2011 26
8.5 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Immuno Chemistry), by Region, Market Share (2011) 28
8.6 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Immuno Chemistry), by Country, Market Share (2011) 29
9 Ortho-Clinical Diagnostics Inc Medical Equipment Market Share Analysis by Category 31
9.1 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 31
9.2 Ortho-Clinical Diagnostics Inc., Asia-Pacific, Category Revenue Share (2011) 33
9.2.1 Ortho-Clinical Diagnostics Inc., Australia, Category Revenue Share (2011) 35
9.2.2 Ortho-Clinical Diagnostics Inc., China, Category Revenue Share (2011) 37
9.2.3 Ortho-Clinical Diagnostics Inc., India, Category Revenue Share (2011) 39
9.2.4 Ortho-Clinical Diagnostics Inc., Japan, Category Revenue Share (2011) 41
9.2.5 Ortho-Clinical Diagnostics Inc., Other Asia-Pacific, Category Revenue Share (2011) 43
9.3 Ortho-Clinical Diagnostics Inc., Europe, Category Revenue Share (2011) 45
9.3.1 Ortho-Clinical Diagnostics Inc., France, Category Revenue Share (2011) 47
9.3.2 Ortho-Clinical Diagnostics Inc., Germany, Category Revenue Share (2011) 49
9.3.3 Ortho-Clinical Diagnostics Inc., Italy, Category Revenue Share (2011) 51
9.3.4 Ortho-Clinical Diagnostics Inc., Spain, Category Revenue Share (2011) 53
9.3.5 Ortho-Clinical Diagnostics Inc., United Kingdom, Category Revenue Share (2011) 55
9.3.6 Ortho-Clinical Diagnostics Inc., Other Europe, Category Revenue Share (2011) 57
9.4 Ortho-Clinical Diagnostics Inc., Middle East and Africa, Category Revenue Share (2011) 58
9.5 Ortho-Clinical Diagnostics Inc., North America, Category Revenue Share (2011) 61
9.5.1 Ortho-Clinical Diagnostics Inc., Canada, Category Revenue Share (2011) 63
9.5.2 Ortho-Clinical Diagnostics Inc., United States, Category Revenue Share (2011) 65
9.6 Ortho-Clinical Diagnostics Inc., South and Central America, Category Revenue Share (2011) 67
9.6.1 Ortho-Clinical Diagnostics Inc., Brazil, Category Revenue Share (2011) 69
9.6.2 Ortho-Clinical Diagnostics Inc., Other South and Central America, Category Revenue Share (2011) 71
10 Key Employees 73
11 Company Statement 74
12 Locations And Subsidiaries 75
12.1 Head Office 75
12.2 Other Locations & Subsidiaries 75
13 Financial Deals Landscape 77
13.1 Ortho-Clinical Diagnostics Inc., Deals Volume Summary, 2007 to YTD 2013 77
14 Ortho-Clinical Diagnostics Inc. Detailed Deal Summary 79
14.1 Private Equity 79
14.1.1 Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 79
14.2 Partnerships 81
14.2.1 Intrinsic Bioprobes Enters Into Licensing Agreement With Ortho-Clinical Diagnostics 81
14.2.2 CeMines Enters Into An Agreement With Ortho-Clinical Diagnostics 82
14.2.3 20/20 GeneSystems Signs An Agreement With Ortho-Clinical Diagnostics 83
14.2.4 Roche Signs Licensing Agreement With Ortho-Clinical Diagnostics And Novartis Vaccines and Diagnostics 84
14.2.5 QIAGEN And Ortho-Clinical Diagnostics Enter Into Licensing Agreement 85
14.2.6 Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement 86
14.2.7 Rapid Biosensor Announces Option Agreement With Ortho-Clinical Diagnostics 88
14.3 Asset Transactions 89
14.3.1 Streck Acquires SickleDex Product Line From Ortho-Clinical Diagnostics 89
15 Recent Developments 90
15.1 Product News 90
15.1.1 Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 90
15.1.2 Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 90
15.1.3 Mar 28, 2012: Ortho-Clinical Announces Availability Of Avioq HTLV-I/II Microelisa System Assay 91
15.1.4 Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 91
15.1.5 Jul 22, 2011: Ortho Clinical Diagnostics Launches VITROS 4600 Chemistry System For Mid-To High-Volume Laboratories 92
15.1.6 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 93
15.1.7 Nov 01, 2010: Ortho-Clinical Diagnostics Gets FDA Clearance For VITROS Intact Parathyroid Hormone (iPTH) Assay 93
15.1.8 Oct 26, 2009: Ortho Clinical Diagnostics Receives FDA Approval For VITROS Hepatitis B Surface Antigen (HBsAg) Assay 94
15.1.9 Oct 23, 2009: Ortho Clinical Diagnostics Introduces FETALSCREEN II Fetal Maternal Hemorrhage Screening Test 95
15.1.10 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 95
15.1.11 Jul 21, 2009: Ortho Clinical Diagnostics Announces US FDA Approval Of The VITROS Anti-HCV Assay For Use On The VITROS 5600 Integrated And 3600 Immunodiagnostic Systems 96
15.1.12 Jan 15, 2009: Ortho Clinical Diagnostics Announces Availability Of Two Next Generation Clinical Diagnostic Platforms In Europe 96
15.1.13 Dec 23, 2008: Ortho Clinical’s VITROS 3600 Immunodiagnostic System Receives 510 (K) Clearance For Laboratory Diagnostics 97
15.1.14 Oct 01, 2007: Ortho-Clinical Diagnostics Introduces Improved Sensitivity Troponin I Assay 97
15.1.15 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of Toxoplasma IgM Assay 98
15.1.16 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of CMV IgG Assay 98
15.1.17 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of Rubella IgM Assay 99
15.2 Product Approvals 99
15.2.1 Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 99
15.2.2 Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 99
15.2.3 Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 100
15.2.4 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 101
15.2.5 Nov 01, 2010: Ortho-Clinical Diagnostics Gets FDA Clearance For VITROS Intact Parathyroid Hormone (iPTH) Assay 101
15.2.6 Oct 26, 2009: Ortho Clinical Diagnostics Receives FDA Approval For VITROS Hepatitis B Surface Antigen (HBsAg) Assay 102
15.2.7 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 103
15.2.8 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 103
15.2.9 Jul 21, 2009: Ortho Clinical Diagnostics Announces US FDA Approval Of The VITROS Anti-HCV Assay For Use On The VITROS 5600 Integrated And 3600 Immunodiagnostic Systems 104
15.2.10 Dec 23, 2008: Ortho Clinical’s VITROS 3600 Immunodiagnostic System Receives 510 (K) Clearance For Laboratory Diagnostics 105
15.3 Other Significant Developments 105
15.3.1 Mar 25, 2010: Ortho-Clinical Diagnostics To Break Ground On Solar Energy Installation At New Jersey Headquarters 105
16 Appendix 107
16.1 Research Methodology 108
16.2 Secondary Research 108
16.3 Primary Research 108
16.4 Models 109
16.5 Forecasts 109
16.6 Expert Panels 109
16.7 GlobalData Consulting 109
16.8 Currency Conversion 110
16.9 Contact Us 111
16.10 Disclaimer 111


【レポート販売概要】

■ タイトル:Ortho-Clinical Diagnostics Inc.:市場シェア分析
■ 英文:Ortho-Clinical Diagnostics Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160532
■ 調査対象地域:グローバル
  • アブレーション技術(アブレータ/切除装置)の世界市場:レーザー/光アブレーション、高周波アブレーション、超音波アブレーション等
    The global ablation technologies market is estimated to grow at a CAGR of 9.6% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the ablation technologies market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 12.8% in the next five years. Factors such as increasing government initiatives for modernization o …
  • 世界のろう付け用素材(Brazing Materials)市場動向(2012-2016)
    TechNavio's analysts forecast the Global Brazing Materials market to grow at a CAGR of 3.02 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in demand for aluminum brazing alloys from the Automotive industry. The Global Brazing Materials market has also been witnessing the increasing use of active brazing materials. However, the increase …
  • アラビアガムの世界市場
    Presently, the demand for confectionery and beverage products is increasing in Asia-Pacific, mainly owing to the increasing disposable incomes of consumers from developing countries of the region. The confectionery segment is the largest application segment in the global gum arabic market, wherein it is used as a stabilizer, thickener, and texturant. With the rising disposable incomes of consumers …
  • ニキビ治療薬の世界市場2016-2020
    Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC). It outlines the market shares for key regions such as the America …
  • モバイルネットワークAPI市場(Mobile Network APIs 2012 – 2016)
    While a large part of the market is yet to understand their technological and strategic significance, Mobile Network APIs play a critical part in carrier networks as a secondary stream of revenue. Mobile Network APIs capitalize on existing network infrastructure to create a vast array of business opportunities for carriers worldwide. In essence, these APIs allow carriers to disseminate a wealth of …
  • モバイル衛星サービス(MSS)の世界市場2016-2020
    About Mobile Satellite Services Mobile satellite services (MSS) provide effective communication services beyond the terrestrial range and serves as an ultimate and appropriate channel in emergency situations. MSS include voice, low-speed data, fax, paging, high-speed data, and broadcast and video on demand. MSS systems are categorized based on their orbital altitudes such as geostationary orbit (G …
  • 梅毒検査の世界市場2015
    The report presents a detailed analysis of the Syphilis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Syphilis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals      …
  • ヒ化ガリウム(GaAs)部品の世界市場2017-2021
    About Gallium Arsenide (GaAs) Components GaAs is increasingly used as a replacement for silicon because of its enhanced electronic properties. GaAs has high saturated electron velocity and electron mobility, which allow GaAs components to function efficiently at frequencies above 250 gigahertz (GHz). Due to the wider band gap, GaAs components are less sensitive to heat compared with silicon-based …
  • 航空機用装飾ラミネートの世界市場2019-2023
    Global Aircraft Decorative Laminates Market: About this market Technavio’s aircraft decorative laminates market analysis considers sales from both film laminates and reinforced laminates. Our analysis also considers the sales of aircraft decorative laminates in APAC, Europe, North America, South America, and MEA. In 2018, the film laminates segment had a significant market share, and this trend is …
  • ペット用ウェアラブルの世界市場2016-2020
    About Pet WearableSmart pet tracking is a connected solution that provides security to pets. Smart pet tracking powered by pet wearable devices allows pet parents keep a tab on their pet's activity and location from the smartphone application. Millions of households are using these devices for their pets as the cost of these devices and the cost of remote monitoring services are inexpensive. Also, …
  • Metastatic Pancreatic Cancer:グローバル臨床試験レビューH2, 2013
    Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Metastatic Pancreatic Cancer Global Clinical Trials Review, H2, 2013" provides data on the Metastatic Pancreatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Pancreatic Cancer . It includes an overview …
  • 黄熱(Yellow Fever):世界の治験レビュー2014年下半期版
    Yellow Fever Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2014" provides data on the Yellow Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Yellow Fever. It includes an overview of the trial numbers and their recruitment status as per the sit …
  • スマートグリッド用センサーの世界市場
    About Smart Grid SensorsSmart grid sensors are compact electrical devices used for detecting and monitoring power system equipment. They track the power line temperatures and weather conditions around the power cables, and are also used to calculate the current carrying capacity of transmission lines. Technavio’s analysts forecast the global Smart Grid Sensors market to grow at a CAGR of 15.28% du …
  • 脱毛クリームの世界市場2016-2020
    About Hair Removal Creams Hair removal cream depilates by chemically dissolving hair that grows on the surface of the skin. They are a temporary solution for removing hairs. On the other hand, electrolysis and laser are permanent hair removal procedures, which are gaining popularity worldwide. However, laser treatment is an expensive solution, thereby restricting its use among high-income group co …
  • 世界のホジキンリンパ腫治療/医薬品市場(2014-2018)
    About Hodgkin's Lymphoma Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the lymphatic system grow unusually and may spread beyond the lymphatic system. …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。